Stem Cells USA & Regenerative Medicine Congress 2012

Stem Cells USA & Regenerative Medicine Congress is the region's largest commercial stem cells conference
Most stem cell companies face two options - go bankrupt or find a partner with deep pockets. Despite there being hundreds of companies with promising technologies, most of them never pass Phase II trials due to lack of funding.

This year’s Stem Cells USA & Regenerative Medicine Congress will focus on strategies and business models to help you navigate this increasingly challenging marketplace, and to ensure your stem cell and regenerative medicine gets to market.